articleCirculationNov 14, 2013Closed access

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Heidelberg University · University Hospital Heidelberg · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

BACKGROUND: In patients with acute pulmonary embolism, systemic thrombolysis improves right ventricular (RV) dilatation, is associated with major bleeding, and is withheld in many patients at risk. This multicenter randomized, controlled trial investigated whether ultrasound-assisted catheter-directed thrombolysis (USAT) is superior to anticoagulation alone in the reversal of RV dilatation in intermediate-risk patients. METHODS AND RESULTS: Fifty-nine patients (63±14 years) with acute main or lower lobe pulmonary embolism and echocardiographic RV to left ventricular dimension (RV/LV) ratio ≥1.0 were randomized to receive unfractionated heparin and an USAT regimen of 10 to 20 mg recombinant tissue plasminogen…

Citation impact

1,094
total citations
FWCI
39.91
Percentile
100%
References
23
Citations per year

Authors

19

Topics & keywords

Keywords
  • Medicine
  • Thrombolysis
  • Pulmonary embolism
  • Heparin
  • Internal medicine
  • Cardiology
  • Randomized controlled trial
  • Surgery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.